Etiology, Evaluation, and Management of Nocturia in Elderly Men and Women

References

• . Stewart RB, Moore MT, May FE, . Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc. 1992;40:1217–1220
   PubMed Web of Science ®Google Scholar
• . Van Kerrebroeck P, Abrams P, Chaikin D, . The standardization of terminology in nocturia: report from the Standardization Subcommittee of the International Continence Society. Neurourol Urodyn. 2002;21:179–183
   PubMed Web of Science ®Google Scholar
• . Bosch JL, Weiss JP. The prevalence and causes of nocturia. J Urol. 2013;189:S86–S92
   Web of Science ®Google Scholar
• . Schatzl G, Temml C, Schmidbauer J, . Cross-sectional study of nocturia in both sexes: analysis of a voluntary health screening project. Urology. 2000;56:71–75
   PubMed Web of Science ®Google Scholar
• . Wein A, Lose GR, Fonda D. Nocturia in men, women and the elderly: a practical approach. BJU Int. 2002;90( Suppl 3):28–31
   PubMed Web of Science ®Google Scholar
• . Irwin DE, Milsom I, Hunskaar S, . State of the art in nocturia. Eur Urol. 2006;50:1306–1314
   PubMed Web of Science ®Google Scholar
• . Tideiksaar R. Preventing falls: how to identify risk factors, reduce complications. Geriatrics. 1996;51:43–55
   PubMed Web of Science ®Google Scholar
• . Jensen J, Ludin-Olssson L, Nyberg L, . Falls among frail older people in residential care. Scand J Public Health. 2002;30:54–61
   PubMed Web of Science ®Google Scholar
• . Van Balen R, Steyerberg EW, Polder JJ, . Hip fracture in elderly patients: outcomes for function, quality of life, and type of residence. Clin Orthop Rel Res. 2001;390:323–343
   Google Scholar
• . Tikkinen KA, Auvinen A, Johnson TM, . A systematic evaluation of factors associated with nocturia—the population-based FINNO study. Am J Epidemiol. 2009;180:361–368
   Google Scholar
• . Scarpa RM. Lower urinary tract symptoms. What are the implications for the patients? Eur Urol. 2001;40:12–20
   PubMed Web of Science ®Google Scholar
• . Kobelt G, Borgstrom F, Mattiasson, . Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int. 2003;91(3):190–195
   PubMed Web of Science ®Google Scholar
• . Tahtien RM, Auviden A, Cartwright R, . Smoking and bladder symptoms in women. Obstet Gynecol. 2011;118(3):643–648
   PubMed Web of Science ®Google Scholar
• . Abrams P, Cardozo L, Fall M, . The standardisation of terminology of lower urinary tract function: report from the Standardization Subcommittee of the International Continence Society. Neurol Urodyn. 2002;21(2):167–178
   PubMed Web of Science ®Google Scholar
• . Rembratt A, Norgaard JP, Anderson KE. Differences between nocturics and non-nocturics in voiding patterns: an analysis of frequency-volume charts from community-dwelling elderly. BJU Int. 2003;91(1):45–50
   PubMed Web of Science ®Google Scholar
• . Koseoglu H, Aslan G, Ozdemir I, . Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology. 2006;67:1188–1192
   PubMed Web of Science ®Google Scholar
• . Cornu JN, Abrams P, Chapple CR, . A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management—a systematic review and meta-analysis. Eur Urol. 2012;62(5):877–890
   PubMed Web of Science ®Google Scholar
• . Weiss JP, Blavis J. Nocturnal polyuria versus overactive bladder in nocturia. Urology. 2002;60(5 Suppl 1):28–32
   PubMedGoogle Scholar
• . Moses AM, Robinson AG, Czernichow P. Clinical and laboratory observations in the adult with diabetes insipidus and related syndromes. In: Czernichow P, Robinson AG, eds. Diabetes Insipidus in Man. Frontiers of Hormone Research, vol 13. Basel, Switzerland: Karger; 1985:56–75
   Google Scholar
• . Weiss JP, Balivas JG, Stember DS. Nocturia in adults: classification and etiology. Neurourol Urodyn. 1998;17(4):462–472
   Google Scholar
• . Adam P. Evaluation and management of diabetes insipidus. Am Fam Physician. 1997;55:2146–2153
   PubMed Web of Science ®Google Scholar
• . Weatherall M. The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis. Neurourol Urodyn. 2004;23(4):302–305
   PubMed Web of Science ®Google Scholar
• . Laureanno P, Ellsworth P. Demystifying nocturia: identifying the cause and tailoring the treatment. Urol Nursing. 2010;30:276–285
   PubMedGoogle Scholar
• . Ely JW, Osheroff JA, Chambliss ML, Ebell MH. Approach to leg edema of unclear etiology. J Am Board Family Med. 2006;19(2):148–160
   PubMed Web of Science ®Google Scholar
• . Appell RA, Sand PK. Nocturia: etiology, diagnosis and treatment. Neurourol Urodyn. 2008;27:34–39
   PubMed Web of Science ®Google Scholar
• . Rembratt A, Riis A, Norgaard JP. Desmopressin treatment in nocturia: an analysis of risk factors for hyponatremia. Neurol Urodyn. 2006;25:105–109
   PubMed Web of Science ®Google Scholar
• . Abrams P, Mattiasson A, Lose GR, . The role of desmopressin treatment in adult nocturia. BJU Int. 2002;90:32–36
   PubMed Web of Science ®Google Scholar
• . Chapple C, Steers W, Norton P. A pooled analysis of 3 phase III studies to evaluate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder. Br J Urol. 2005;95(7):993–995
   Google Scholar
• . Nitti VW, Dmochowski R, Sand PK, . Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol. 2007;178(6):2488–2494
   PubMed Web of Science ®Google Scholar
• . Johnson TM 2nd, Burgio KL, Redden DT, . Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc. 2005;43:846–850
   Google Scholar
• . Brubaker L, FitzGerald MP. Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J. 2007;18(7):737–741
   PubMed Web of Science ®Google Scholar
• . Kaplan SA, Walmsley J, Te AE. Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol. 2005;174:2273–2275
   PubMed Web of Science ®Google Scholar
• . MacDiarmid S, Ellsworth P, Ginsberg D, . The safety and efficacy of once-daily trospium chloride extended release in male patients with overactive bladder. Oral presentation at the Western Section Meeting of the AUA; 2009; Las Vegas, NV
   Google Scholar
• . Elhiali M, Emberton M, Matzkin H, ; The ALF-ONE Study Group. Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in “real-life” practice. BJU. 2006;97:513–519
   PubMed Web of Science ®Google Scholar
• . Desgrandchamps F, Droupy S, Irani J, . Effect of dutasteride on the symptoms of benign prostatic hyperplasia and patient quality of life and discomfort, in clinical practice. BJU Int. 2006;98:83–88
   PubMed Web of Science ®Google Scholar
• . Johnson TM 2nd, Burrows PJ, Kusek JW. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol. 2007;178:2045–2051
   PubMed Web of Science ®Google Scholar